drugset / Trial / NCT07170540
UNC Cashew Sublingual Immunotherapy
Phase 2
Not yet recruiting
45 enrolled
University of North Carolina, Chapel Hill
Food Allergy Research & Education · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The CASCADES study will investigate the safety and efficacy of sublingual immunotherapy (SLIT) for the treatment of cashew allergy in children ages 1-11 years old. Primary efficacy will be assessed after 18 months of cashew SLIT. Lab studies and an oral food challenge after 6 months of cashew SLIT will help determine how quickly cashew SLIT begins to take effect.
Timeline
- Start
- 2026-06
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cashew sublingual immunotherapy | Unknown | — | Other |
Indications
No indication recorded.